Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint

Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint

To date, there are no clinically effective neuroprotective or disease-modifying treatments that can halt Parkinson's disease (PD) progression. The current clinical approach focuses on symptomatic management. This failure may relate to the complex neurobiology underpinning the development of PD...

Full description

Bibliographic Details
Main Authors: Carolina Sportelli, Daniele Urso, Peter Jenner, K. Ray Chaudhuri
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Neurology
Subjects:
Parkinson's disease
prodromal
metformin
neuroprotection
idiopathic REM behavior disorder
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.00556/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2020.00556/full

Similar Items